checkAd

     173  0 Kommentare Organigram Announces Results of Annual and Special Meeting, including Shareholder Approval of C$124.6 Million Investment from BAT - Seite 2

    2.435%

    Karina Gehring

    21,045,939

    97.574%

    523,322

    2.426%

    The biographies of the Company’s directors are set out in the Circular, which is available under the Company’s profile on SEDAR+ at www.sedarplus.ca. and on EDGAR at www.sec.gov.

    Committee Composition

    Following the Meeting, the Board has reviewed and approved the composition of its Committees. The Audit Committee now consists of Stephen Smith (Chair), Dexter John, Marni Wieshofer and Simon Ashton. The Compensation Committee now consists of Sherry Porter (Chair), Geoff Machum and Karina Gehring. The Investment Committee now consists of Dexter John (Chair), Stephen Smith, Marni Wieshofer and Simon Ashton. The Governance, Nominating and Sustainability Committee remains unchanged consisting of Geoff Machum (Chair), Sherry Porter and Dexter John.

    Appointment of Auditor

    Further, an ordinary resolution approving the appointment of KPMG LLP as the Company’s auditor until the next annual meeting of the shareholders of the Company or until its successor is duly appointed and authorizing the directors of the Company to fix its remuneration was approved by the affirmative vote of 96.999% of the votes represented at the Meeting.

    Shareholder Approval of Investment and Articles of Amendment

    At the Meeting, an ordinary resolution approving the previously announced C$124.6 million follow-on strategic equity investment by the Investor in the Company (the “Investment”), was approved by the affirmative vote of 96.169% of the votes represented at the Meeting (or 86.926% of the voted represented at the Meeting excluding the votes attached to the common shares held by the Investor in accordance with Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions and the rules of the Toronto Stock Exchange (the “TSX”)).

    Subject to the satisfaction or waiver of the other conditions to closing contained in the subscription agreement (the “Subscription Agreement”) with the Investor dated November 5, 2023, as amended on December 20, 2023, the closing of the first tranche of the Investment is expected to close on or around January 23, 2024.

    In addition, a special resolution approving the amendment of the Company’s articles to create a new class of Class A preferred shares (the “Preferred Shares”) to be issued by the Company to the Investor in the Investment was approved by the affirmative vote of 92.139% of the votes represented at the Meeting.

    Seite 2 von 4


    Diskutieren Sie über die enthaltenen Werte


    Business Wire (engl.)
    0 Follower
    Autor folgen

    Organigram Announces Results of Annual and Special Meeting, including Shareholder Approval of C$124.6 Million Investment from BAT - Seite 2 Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI) announced today the results of voting at its annual general and special meeting of shareholders (the “Shareholders”) held virtually on January 18, 2024 (the …